EligibleTrials

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Recruiting · NCT06590896 · Interventional (participants receive a specific treatment) · Lead sponsor: Ono Pharmaceutical Co., Ltd.

View the official record on ClinicalTrials.gov →
Epilepsy

Interventions studied

Cenobamate

What this trial is about

To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures

Who can take part

Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

29 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.